Low-density addressable array for the detection and typing of the human papillomavirus

Diagnostic Microbiology and Infectious Disease

Volumn 48, Issue 1, 2004, Pages 23-31

  Delrio Lafreniere, Susie A ^a   Browning, Megan K ^a   McGlennen, Ronald C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUOROCHROME; VIRUS DNA;

BACTERIUM IDENTIFICATION; CLASSIFICATION; COMPARATIVE STUDY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DNA DETERMINATION; DNA MICROARRAY; DNA PROBE; DNA SEQUENCE; EPIDEMIOLOGY; FEMALE; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

EID: 0842324612     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2003.09.007     Document Type: Conference Paper

References (37)

1. Altschul S.F., Madden T.L., Schaffer A.A., et al. Gapped BLAST and PSI-BLAST a new generation of protein database search programs . Nucleic Acids Res. 25:1997;3389-33402.
2. American Cancer Society (2002) Facts and figures. American Cancer Society, New York, NY. (http://www.cancer.org/docroot/STT/stt_0.asp).
3. Bernard H.U., Chan S.Y., Manos M.M., et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis. 170:1994;1077-1085.
4. Bosch F.X., Manos M.M., Munoz N., et al. Prevalence of human papillomavirus in cervical cancer a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group . J Nat Cancer Inst. 87:1995;796-802.
5. Bosch F.X., Munoz N. The viral etiology of cervical cancer. Virus Res. 89:2002;183-190.
6. Cope J.U., Hildesheim A., Schiffman M.H., et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol. 35:1997;2262-2265.
7. Corpet F. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16:1988;10881-10890.
8. Cox J., Lorincz A., Schiffman M., et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 172:1995;946-954.
9. Dubiley S., Kirillov E., Mirzabekov A. Polymorphism analysis and gene detection by minisequencing on an array of gel-immobilized primers. Nucleic Acids Res. 27:1999;e19.
10. Gerry N.P., Witowski N.E., Day J., et al. Universal DNA array with polymerase chain reaction/ligase detection reaction (PCR/LDR) for multiplex detection of low abundance mutations. J Mol Biol. 292:1999;251-262.
11. Graves D.J., Su H.J., McKenzie S.E., et al. System for preparing microhybridization arrays on glass slides. Anal Chem. 70:1998;5085-5092.
12. Gravitt P.E., Manos M.M. Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. IARC Scientific Publishers. 121:1992;133.
13. Hart K.W., Williams O.M., Thelwell N., et al. Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples. J Clin Microbiol. 39:2001;3204-3212.
14. Hildesheim A., Schiffman M.H., Gravitt P.E., et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 169:1994;235-240.
15. Ho G.Y., Burk R.D., Klein S., et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Nat Cancer Inst. 87:1995;1365-1371.
16. Hughes S.A., Sun D., Gibson C., et al. Managing atypical squamous cells of undetermined significance (ASCUS) human papillomavirus testing, ASCUS subtyping, or follow-up cytology? Am J Obstet Gynecol. 186:2002;396-403.
17. +-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 35:1997;791-795.
18. Karlsen F., Kalantari M., Jenkins A., et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 34:1996;2095-2100.
19. Lytwyn A., Sellors J.W., Mahony J.B., et al. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities a randomized trial . Can Med Assoc J. 163:2000;701-707.
20. Maceneaney P.M., Malone D.E. The meaning of diagnostic test results a spreadsheet for swift data analysis . Clin Radiol. 55:2000;227-235.
21. Myers G., Lu H., Calef C., et al. Heterogeneity of papillomaviruses. Semin Cancer Biol. 7:1996;349-358.
22. Meyer T., Arndt R., Christophers E., et al. Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis. 178:1998;252-255.
23. Poljak M., Seme K. Rapid detection and typing of human papillomaviruses by consensus polymerase chain reaction and enzyme-linked immunosorbent assay. J Virol Meth. 56:1996;231-238.
24. + primer systems . J Clin Microbiol. 35:1997;1304-1310.
25. Resnik R.M., Manos M.M., et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Nat Cancer Inst. 82:1990;1477-1484.
26. Simel D.L., Samsa G.P., Matchar D.B. Likelihood ratios with confidence sample size estimation for diagnostic test studies . J Clin Epidemiol. 44:1991;763-770.
27. Solomon D., Schiffman M., Tarone R., et al. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance baseline results from a randomized trial . [comment] J Nat Cancer Inst. 93:2001;293-299.
28. Smits H.L. The use of consensus PCR and direct sequence analysis for the identification of HPV. Methods Mol Biol. 50:1996;109-126.
29. Snijders P., Meijer C., Walboomers J. Degenerate primers based on highly conserved regions of amino acid sequence in papillomaviruses can be used in a generalized polymerase chain reaction to detect productive human papillomavirus infection. J Genet Virol. 72:1991;2781-2786.
30. Strauss S., Jordens J.Z., Desselberger U., et al. Single-tube real-time nested polymerase chain reaction for detecting human papillomavirus DNA. Diagn Mol Pathol. 9:2000;151-157.
31. Szuhai K., Sandhaus E., Kolkman-Uljee S.M., et al. A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction. Am J Pathol. 159:2001;1651-1660.
32. + PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol. 40:2002;779-787.
33. van Doorn L.J., Quint W., Kleter B., et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol. 40:2002;979-983.
34. Venturoli S., Cricca M., Bonvicini F., et al. Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen concordance and correlation with cytological results . J Clin Virol. 25:2002;177-185.
35. Walboomers J.M.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:1999;12-19.
36. Witowski, N. E., Leiendecker-Foster, C., Gerry, N. P., et al (2000). Microarray-based detection of select cardiovascular disease markers. Biotechniques, 29, 936-944.
37. Wright J., Cox M., Twiggs L.B., et al. Consensus guidelines for the management of women with cervical cytological abnormalities. J Am Med Assoc. 287:2001;2120-2129.